Drugs · acquisition-cost intelligence
Methylin
Methylphenidate HCl· ingredient methylphenidate· METHYLPHENIDATE 10 mg/5mL; METHYLPHENIDATE 5 mg/5mL; METHYLPHENIDATE HYDROCHLORIDE 10 mg/5mL; METHYLPHENIDATE HYDROCHLORIDE 5 mg/5mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$0.11303
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per ML — the trend nobody else shows. 7 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other methylphenidate products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.
| Product | NADAC / ML | vs this |
|---|---|---|
| Ritalin | $0.16210 | +$0.04910 |
| Methylphenidate Hydrochloride | $0.49387 | +$0.38080 |
| Methylphenidate Hydrochloride | $0.66777 | +$0.55470 |
| Methylphenidate Hydrochloride Extended-Release | $0.69976 | +$0.58670 |
| CONCERTA | $0.69976 | +$0.58670 |
| methylphenidate hydrochloride CD | $1.49 | +$1.38 |
| Methylphenidate Hydrochloride | $1.91 | +$1.80 |
| Methylphenidate Hydrochloride (LA) | $2.31 | +$2.20 |
Medicare Part D coverage · CY2026
On 249 plan formularies · typical tier 4
Prior auth 37% · Step therapy 0% · Quantity limit 86% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.